BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23551093)

  • 1. Phosphoinositide 3-kinase and INPP4B in human breast cancer.
    Bertucci MC; Mitchell CA
    Ann N Y Acad Sci; 2013 Mar; 1280():1-5. PubMed ID: 23551093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers.
    Fedele CG; Ooms LM; Ho M; Vieusseux J; O'Toole SA; Millar EK; Lopez-Knowles E; Sriratana A; Gurung R; Baglietto L; Giles GG; Bailey CG; Rasko JE; Shields BJ; Price JT; Majerus PW; Sutherland RL; Tiganis T; McLean CA; Mitchell CA
    Proc Natl Acad Sci U S A; 2010 Dec; 107(51):22231-6. PubMed ID: 21127264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The INPP4B paradox: Like PTEN, but different.
    Hamila SA; Ooms LM; Rodgers SJ; Mitchell CA
    Adv Biol Regul; 2021 Dec; 82():100817. PubMed ID: 34216856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE; Shokat KM
    Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Role of INPP4B in Tumor and Metastasis Suppression through Regulation of PI3K-AKT Signaling at Endosomes.
    Li Chew C; Lunardi A; Gulluni F; Ruan DT; Chen M; Salmena L; Nishino M; Papa A; Ng C; Fung J; Clohessy JG; Sasaki J; Sasaki T; Bronson RT; Hirsch E; Pandolfi PP
    Cancer Discov; 2015 Jul; 5(7):740-51. PubMed ID: 25883022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INPP4B: the new kid on the PI3K block.
    Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
    Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
    Vo TT; Fruman DA
    Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphoinositide signaling in cancer: INPP4B Akt(s) out.
    Woolley JF; Dzneladze I; Salmena L
    Trends Mol Med; 2015 Sep; 21(9):530-2. PubMed ID: 26150301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN.
    Pianetti S; Arsura M; Romieu-Mourez R; Coffey RJ; Sonenshein GE
    Oncogene; 2001 Mar; 20(11):1287-99. PubMed ID: 11313873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer.
    Gasser JA; Inuzuka H; Lau AW; Wei W; Beroukhim R; Toker A
    Mol Cell; 2014 Nov; 56(4):595-607. PubMed ID: 25458846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
    Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
    Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosome and INPP4B.
    Chew CL; Chen M; Pandolfi PP
    Oncotarget; 2016 Jan; 7(1):5-6. PubMed ID: 26700619
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling.
    Gewinner C; Wang ZC; Richardson A; Teruya-Feldstein J; Etemadmoghadam D; Bowtell D; Barretina J; Lin WM; Rameh L; Salmena L; Pandolfi PP; Cantley LC
    Cancer Cell; 2009 Aug; 16(2):115-25. PubMed ID: 19647222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer--loss of PTEN predicts resistance to treatment.
    Pandolfi PP
    N Engl J Med; 2004 Nov; 351(22):2337-8. PubMed ID: 15564551
    [No Abstract]   [Full Text] [Related]  

  • 15. Estrogen receptor β regulates AKT activity through up-regulation of INPP4B and inhibits migration of prostate cancer cell line PC-3.
    Chaurasiya S; Wu W; Strom AM; Warner M; Gustafsson JÅ
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26347-26355. PubMed ID: 33020300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated PI3K/Akt/PTEN pathway is a marker of a short disease-free survival in node-negative breast carcinoma.
    Capodanno A; Camerini A; Orlandini C; Baldini E; Resta ML; Bevilacqua G; Collecchi P
    Hum Pathol; 2009 Oct; 40(10):1408-17. PubMed ID: 19428048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms.
    Perez-Lorenzo R; Gill KZ; Shen CH; Zhao FX; Zheng B; Schulze HJ; Silvers DN; Brunner G; Horst BA
    J Invest Dermatol; 2014 May; 134(5):1359-1368. PubMed ID: 24288008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
    Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
    Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. INPP4B Is a PtdIns(3,4,5)P3 Phosphatase That Can Act as a Tumor Suppressor.
    Kofuji S; Kimura H; Nakanishi H; Nanjo H; Takasuga S; Liu H; Eguchi S; Nakamura R; Itoh R; Ueno N; Asanuma K; Huang M; Koizumi A; Habuchi T; Yamazaki M; Suzuki A; Sasaki J; Sasaki T
    Cancer Discov; 2015 Jul; 5(7):730-9. PubMed ID: 25883023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphoinositide 3-kinase signaling in autoimmunity.
    Oak JS; Fruman DA
    Autoimmunity; 2007 Sep; 40(6):433-41. PubMed ID: 17729037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.